Publications | Centro de Investigaciones Biológicas Margarita Salas - CIB Margarita Salas

Back

López-Trascasa, M., Alonso-Melgar, Á., Melgosa-Hijosa, M., Espinosa-Román, L., Lledín-Barbancho, M.D., García-Fernández, E., Rodríguez de Córdoba, S., Sánchez-Corral, P. [2021]. Case Report: Combined Liver-Kidney Transplantation to Correct a Mutation in Complement Factor B in an Atypical Hemolytic Uremic Syndrome Patient. Frontiers in Immunology. doi: 10.3389/fimmu.2021.751093

Corvillo, F., González-Sánchez, L., López-Lera, A., Arjona, E., Ceccarini, G., Santini, F., Araújo-Vilar, D., Brown, R.J., Villarroya, J., Villarroya, F., de Córdoba, S.R., Caballero, T., Nozal, P., López-Trascasa, M. [2021]. Complement factor d (Adipsin) levels are elevated in acquired partial lipodystrophy (barraquer–simons syndrome). International Journal of Molecular Sciences. 22(12):6608. doi: 10.3390/ijms22126608.

Martín-Merinero, H., Zhang, Y., Arjona, E., del Angel, G., Goodfellow, R., Gómez-Rubio, E., Ji, RR., Michelena, M., Smith, RJH., Rodríguez de Córdoba, S. [2021]. Functional characterization of 105 Factor H variants associated with atypical haemolytic uremic syndrome; lessons for variant classification. Blood doi: 10.1182/blood.2021012037.

García-Fernández, J., Vilches-Arroyo, S., Olavarrieta, L., Pérez-Pérez, J., Rodríguez de Córdoba, S. [2021]. Detection of Genetic Rearrangements in the Regulators of Complement Activation RCA Cluster by High-Throughput Sequencing and MLPA. Methods in Molecular Biology. 2227:159-178.

Caravaca-Fontán, F., Díaz-Encarnación, M., Cabello, V., Ariceta, G., Quintana, L., Marco, H., Barros, X., Ramos Terrada, N., Rodríguez-Mendiola, N., Cruz, S., Fernández-Juarez, G., Rodríguez, A., Pérez de José, A., Rabasco, C., Rodado, R., Fernández Lorente, ML., Pérez Gómez, V., Avila, A., Bravo, L., Espinosa, N., Allende, N., Sánchez de la Nieta, M., Rodríguez, E., Olea, T., Melgosa, M., Huerta, A., Miquel-Rodríguez, R., Mon, C., Fraga, G., de Lorenzo, A., Bordignon, J., Cano Megías, M., González, F., Shabaka, A., Fenollosa, MA., Martín-Penagos, L., Da Silva, I., Alonso Titos, J., Rodríguez de Córdoba, S., Goicoechea de Jorge, E. Praga, M.,, on behalf of the Spanish Group for the Study of Glomerular Diseases (GLOSEN). [2021]. Longitudinal Change in Proteinuria and Kidney Outcomes in C3 Glomerulopathy. Nephrol. Dial Transplant. doi: 10.1093/ndt/gfab075.

Martín-Merinero, H., Subías, M., Pereda, A., Gómez-Rubio, E., Juana-López, L., Fernández Rivera, C., Goicoechea de Jorge, E., Martín-Santamaría, S., Cañada, FJ, Rodríguez de Córdoba, S. [2021]. Molecular bases for the association of FHR-1 with atypical hemolytic uremic syndrome and other diseases. Blood 137:3484-3494.

Sánchez-Moreno, A., de la Cerda, F., Rodríguez-Barba, A., Fijo, J., Bedoya, R., Arjona, E. and Rodríguez de Córdoba, S. [2020]. Is the atypical hemolytic uremic syndrome risk polymorphism in Membrane Cofactor Protein MCPggaac relevant in kidney transplantation? A case report. Pediatric Transplantation. doi: 10.1111/petr.13903

Pesce, F., Diletta Stea, E., Divella, C., Accetturo, M., Laghetti, P., Gallo, P., Rossini, M., Cianciotta, F., Crispino, L., Granata, A., Battaglia, M., Lucarelli, G., Rodríguez de Córdoba, S., Stallone, G., Gesualdo, L. and Castellano, G. [2020]. DelCFHR3-1 influences graft survival in transplant patients with IgA nephropathy via complement mediated cellular senescence. Am. J. Transplant. 21:838-845.

Caravaca-Fontán, F., Díaz-Encarnación, M.M., Lucientes, L., Cavero, T., Cabello, V., Ariceta, G., Quintana, L.F., Marco, H., Barros, X., Ramos, N., Rodríguez-Mendiola, N., Cruz, S., Fernández-Juárez, G., Rodríguez, A., José, A.P., Rabasco, C., Rodado, R., Fernández, L., Gómez, V.P., Ávila, A.I., Bravo, L., Lumbreras, J., Allende, N., Nieta, M.D.S.L., Rodríguez, E., Olea, T., Melgosa, M., Huerta, A., Miquel, R., Mon, C., Fraga, G., Lorenzo, A., Draibe, J., Cano-Megías, M., González, F., Shabaka, A., López-Rubio, M.E., Fenollosa, M.Á., Martín-Penagos, L., Silva, I.D., Titos, J.A., Córdoba, S.R., Jorge, E.G., Praga, M., Spanish Group for the Study of Glomerular Diseases GLOSEN [2020]. Mycophenolate mofetil in c3 glomerulopathy and pathogenic drivers of the disease. Clinical Journal of the American Society of Nephrology. 15:1287-1298.

Portoles, J., Huerta, A., Arjona, E., Gavela, E., Agúera, M., Jiménez, C., Cavero, T. Marrero, D., Rodríguez de Córdoba, S., Diekmann, F., on behalf of MATRIX investigators. [2020]. Characteristics, management and outcomes of atypical haemolytic uremic syndrome in kidney transplant patients: a retrospective national study. Clin. Kid. J. 14:1173-1180.

Arjona, E., Huerta, A., Goicoechea de Jorge, E., Rodríguez de Córdoba, S. [2020]. The familial risk of developing atypical Hemolytic Uremic Syndrome. Blood. 136:1558-1561

Lumbreras, J., Subias, M., Espinosa, N., Ferrer, J.M., Arjona, E., Rodríguez de Córdoba, S. [2020]. The Relevance of the MCP Risk Polymorphism to the Outcome of aHUS Associated With C3 Mutations. A Case Report. Frontiers in Immunology. doi: 10.3389/fimmu.2020.01348

Martínez-López, D., Roldan-Montero, R., García-Marqués, F., Nuñez, E., Jorge, I., Camafeita, E., Minguez, P., Rodriguez de Cordoba, S., López-Melgar, B., Lara-Pezzi, E., Fernández-Ortiz, A., Ibáñez, B., Valdivielso, J.M., Fuster, V., Michel, J.-B., Blanco-Colio, L.M., Vázquez, J., Martin-Ventura, J.L. [2020]. Complement C5 Protein as a Marker of Subclinical Atherosclerosis. Journal of the American College of Cardiology. 75:1926-1941.

Urban, A., Volokhina, E., Felber, A., Stasitojc, G., Blom, AM., Jongerius, I., Van den Heuvel, L., Thiel, M., Oldziej, S., Arjona, E., Rodríguez de Córdoba, S. and Okrój, M. [2020]. Gain-of-function mutation in complement C2 protein identified in patient with atypical hemolytic uremic syndrome (aHUS) J. Allergy Clin. Immunol. 146:916-919.e11

Cavero, T., Arjona, E., Soto, K., Caravaca, F., Rabasco, C., Bravo, L., De la Cerda, F., Martín, N., Blasco, M., Avila, A., Huerta, A., Cabello-Chávez, V., Jarque, A., Alcázar, C., Fulladosa, X., Carbayo, J., Anaya, S., Cobelo, C., Ramos, N., Iglesias Lamas, E., Baltar, J., Martínez-Gallardo, R., Pérez-Tamajón, L., Morales, E., González, R., Macía, M., Draibe, J., Pallardo, L., Quintana, L., Espinosa, M., Barros, X., Pereira, F., Cao, M., Moreno, JA., Rodríguez de Córdoba, S., Praga, M., and Spanish Group for the Study of Glomerular Diseases (GLOSEN) [2019]. Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome. Kidney Int. 96:995-1004

Luque, A., Serrano, I., Ripoll, E., Malta, C., Gomà, M., Blom, AM., Grinyó, JM., Rodríguez de Córdoba, S., Torras, J., and Aran, JM. [2020]. Noncanonical immunomodulatory activity of complement regulator C4BP(β-) limits the development of lupus nephritis. Kidney Int. 97:551-566

Jager, NM., Van Zanden, JE., Subías, M., Leuvenink, HGD., Daha, MR., Rodríguez de Córdoba, S., Poppelaars, F. and Seelen, MA. [2019]. Blocking complement factor B activation reduces renal injury and inflammation in a rat brain death model. Frontiers in Immunology doi:10.3389/fimmu.2019.02528.

Gómez, S., Querol-García, J., Sánchez-Barrón, G., Subias, M., González-Alsina, À., Franco-Hidalgo, V., Albertí, S., De Córdoba, S.R., Fernández, F.J., Vega, M.C. [2019]. The antimicrobials anacardic acid and curcumin are not-competitive inhibitors of Gram-positive bacterial pathogenic glyceraldehyde-3-phosphate dehydrogenase by a mechanism unrelated to human C5A anaphylatoxin binding. Frontiers in Microbiology. 10:-.

Praga, M., Rodríguez de Córdoba, S. [2019]. Secondary atypical hemolytic uremic syndromes in the era of complement blockade. Kidney International. 95:1298-1300.

Rodríguez de Córdoba, S., Espinosa Hernández, M. [2019]. Kidney, hypertension and complement activation. In search of new therapeutic targets . Nefrologia. 39:111-114.